New hope for hard-to-treat cancers? first human trial launches

NCT ID NCT05005403

Recruiting now Disease control Sponsor: AbbVie Source: ClinicalTrials.gov ↗

First seen Oct 31, 2025 · Last updated May 13, 2026 · Updated 23 times

Summary

This early-stage study tests a new drug called azirkitug, alone or with other medicines, in people with advanced solid tumors like lung, head/neck, and other cancers. The goal is to find safe doses and check side effects. About 694 adults will take part at sites worldwide.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Aichi Cancer Center Hospital /ID# 250405
RECRUITING

Nagoya, Aichi-ken, 464-8681, Japan
Asan Medical Center /ID# 252289
RECRUITING

Seoul, Seoul Teugbyeolsi, 05505, South Korea
CHA Bundang Medical Center /ID# 252291
RECRUITING

Seongnam, Gyeonggido, 13496, South Korea
Carolina BioOncology Institute /ID# 232597
RECRUITING

Huntersville, North Carolina, 28078, United States

Contact Phone: •••-•••-••••
City of Hope - Orange County Lennar Foundation Cancer Center /ID# 278589
RECRUITING

Irvine, California, 92618, United States
City of Hope National Medical Center /ID# 276272
RECRUITING

Duarte, California, 91010, United States
Community Health Network, Inc. /ID# 243011
RECRUITING

Indianapolis, Indiana, 46250-2042, United States
Duke Cancer Institute /ID# 276267
RECRUITING

Durham, North Carolina, 27710, United States
Fort Wayne Medical Oncology and Hematology, Inc /ID# 232593
RECRUITING

Fort Wayne, Indiana, 46804, United States
Hadassah Medical Center-Hebrew University /ID# 252287
RECRUITING

Jerusalem, 91120, Israel
Kansai Medical University Hospital /ID# 276805
RECRUITING

Hirakata-shi, Osaka, 573-1191, Japan
Kobe University Hospital /ID# 250409
RECRUITING

Kobe, Hyōgo, 650-0017, Japan
M Health Fairview University of Minnesota Medical Center - East Bank /ID# 276200
RECRUITING

Minneapolis, Minnesota, 55455, United States
Meir Medical Center /ID# 277327
RECRUITING

Kfar Saba, Central District, 4428164, Israel
NEXT Oncology /ID# 243007
RECRUITING

San Antonio, Texas, 78229, United States
NEXT Oncology Austin /ID# 243005
RECRUITING

Austin, Texas, 78705-1171, United States
National Cancer Center /ID# 252290
RECRUITING

Goyang-si, Gyeonggido, 10408, South Korea
National Cancer Center Hospital /ID# 238372
RECRUITING

Chuo-ku, Tokyo, 104-0045, Japan
National Cancer Center Hospital East /ID# 238840
RECRUITING

Kashiwa-shi, Chiba, 277-8577, Japan
National Cheng Kung University Hospital /ID# 252262
RECRUITING

Tainan, 704, Taiwan
National Taiwan University Hospital /ID# 251894
RECRUITING

Taipei City, Taipei, 100, Taiwan
Nebraska Cancer Specialists - Omaha - Wright Street /ID# 247399
RECRUITING

Omaha, Nebraska, 68130, United States
Next Oncology - Irving /ID# 276254
RECRUITING

Irving, Texas, 75039, United States
Norton Cancer Institute /ID# 248903
RECRUITING

Louisville, Kentucky, 40241-2832, United States
Princess Margaret Cancer Centre /ID# 276275
RECRUITING

Toronto, Ontario, M5G 2M9, Canada
Rabin Medical Center. /ID# 250497
RECRUITING

Petah Tikva, 4941492, Israel
Rambam Health Care Campus /ID# 238333
RECRUITING

Haifa, 3109601, Israel
START Midwest /ID# 248685
RECRUITING

Grand Rapids, Michigan, 49546-7062, United States
Shaare Zedek Medical Center /ID# 276244
RECRUITING

Jerusalem, 9103102, Israel
Shamir Medical Center /ID# 276238
RECRUITING

Beer Ya'akov, Central District, 70300, Israel
Shizuoka Cancer Center /ID# 250408
RECRUITING

Sunto-gun, Shizuoka, 411-8777, Japan
South Texas Accelerated Research Therapeutics (START) /ID# 276268
RECRUITING

San Antonio, Texas, 78229, United States
Start Mountain Region /ID# 276270
RECRUITING

West Valley City, Utah, 84119, United States
Taipei Medical University Hospital /ID# 252450
RECRUITING

Taipei, 11031, Taiwan
Taipei Medical University Shuang Ho Hospital /ID# 252449
RECRUITING

New Taipei City, 23561, Taiwan
Tel Aviv Sourasky Medical Center /ID# 276591
RECRUITING

Tel Aviv, Tel Aviv, 6423906, Israel
The Catholic University of Korea, Seoul St. Marys Hospital /ID# 252867
RECRUITING

Seoul, Seoul Teugbyeolsi, 06591, South Korea
The Chaim Sheba Medical Center /ID# 238332
RECRUITING

Ramat Gan, Tel Aviv, 5265601, Israel
The University of Texas MD Anderson Cancer Center /ID# 270059
RECRUITING

Houston, Texas, 77030, United States
Tom Baker Cancer Centre /ID# 276206
RECRUITING

Calgary, Alberta, T2N 4N2, Canada
Tri-Service General Hospital /ID# 252263
RECRUITING

Taipei, 11490, Taiwan
University of Illinois Hospital and Health Sciences System /ID# 251750
RECRUITING

Chicago, Illinois, 60607, United States
Virginia Cancer Specialists - Fairfax /ID# 232592
RECRUITING

Fairfax, Virginia, 22031, United States
Wakayama Medical University Hospital /ID# 276806
COMPLETED

Wakayama, Wakayama, 641-8510, Japan
Yonsei University Health System Severance Hospital /ID# 252288
RECRUITING

Seoul, Seoul Teugbyeolsi, 03722, South Korea

Conditions

Explore the condition pages connected to this study.

GASTRIC-ESOPHAGEAL CANCER HEAD AND NECK SQUAMOUS CELL CARCINOMA HIGH GRADE SEROUS OVARIAN CANCER MICRO SATELLITE STABLE COLORECTAL CANCER MICRO SATELLITE STABLE COLORECTAL CANCER NON-SMALL CELL LUNG CANCER PANCREATIC CANCER TRIPLE NEGATIVE BREAST CANCER